Take a look at a selection of our recent media coverage:
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry
8th November 2021
Characteristics and Outcomes of Patients With Severe Aortic Stenosis Discussed by the Multidisciplinary ‘‘Heart Team” According to Treatment Allocation
25th October 2021
‘Valve for Life’: tackling the deficit in transcatheter treatment of heart valve disease in the UK
10th August 2021
Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes
30th June 2021
The cost-effectiveness of TAVR in low surgical risk patients with severe aortic stenosis
2nd June 2021
SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics
1st June 2021
Effective Operational Management in the Cardiac Catheterization Laboratory (Review paper)
Health Status after Transcatheter vs Surgical Aortic Valve Replacement in Low-risk Patients with Aortic Stenosis
Transcatheter Aortic-Valve Replacement with a Balloon Expandable Valve in Low-Risk Patients
Thirty-day readmission after TAVR in the United States: Insights from the Nationwide Readmission Database